نتایج جستجو برای: dr4

تعداد نتایج: 1362  

خسروی, فریده, دواچی, فریدون, شکرآبی, مهدی, نیک بین, بهروز,

Close relation of rheumatoid arthritis (RA) and HLA antigen DR4 has been reported with incidence as high"as 50-75% (3) In this study 34 patients in different stages of RA and treated with different drugs were studied for HLA DR4 antigen. 100 healthy individuals working in the lab. were tested as controls. DR4 were noted in patients with 3/25 risk, RR=3.25 (1'<0.01) These findings will increase ...

تقی‌پور, رضا, جمشیدی, احمد رضا, سالاری, امیرحسین, طهرانی بنی‌هاشمی, سید آرش,

Background: There are several evidences that genetic factors besides environmental triggers have important role in initiating the rheumatoid arthritis (RA). The aim of this study was to investigate the association of rheumatoid arthritis with different subtypes of HLA DR4 in Iranian patients. Methods: In an un-matched case control study, 110 rheumatoid arthritis patients (case) and 56 knee ost...

Journal: :eLife 2021

Colorectal cancer (CRC) remains a leading cause of death, and its mortality is associated with metastasis chemoresistance. We demonstrate that oxaliplatin-resistant CRC cells are sensitized to TRAIL-mediated apoptosis. Oxaliplatin-resistant exhibited transcriptional downregulation caspase-10, but this had minimal effects on TRAIL sensitivity following CRISPR-Cas9 deletion caspase-10 in parental...

Journal: :Oncology reports 2007
Tatsushi Yoshida Takumi Shiraishi Mano Horinaka Miki Wakada Toshiyuki Sakai

Death receptor 4 (DR4) is a receptor of the antitumor death ligand, TNF-related apoptosis-inducing ligand (TRAIL), and is considered a promising molecular target for cancer therapy. Here, we show a novel regulation of DR4 protein. Tunicamycin treatment, which is an inducer of endoplasmic reticulum (ER)-stress, generated a lower molecular-weight pattern of DR4, but not DR5 protein in prostate ca...

Journal: :British Journal of Surgery 2022

Abstract Introduction The genotypes HLA DR3/DR4, DR3/DR3, DR4/DR4 are associated with a predisposition to diabetes. This study evaluated UK recipient outcomes after pancreas transplantation from donors diabetes-associated genotypes. Methods Data on all transplants 2004–2019 was obtained the NHSBT-UK Registry, n=2,938. HLA-DR type recorded for organ donors. Re-transplants and those missing patie...

Journal: :Diabetes 1989
D Owerbach S Gunn K H Gabbay

DNA from 164 Caucasian type I (insulin-dependent) diabetic patients and 200 Caucasian nondiabetic control blood donors were analyzed by the polymerase chain reaction technique for HLA-DR4 and the associated Dw and DQB subtypes of DR4. The DQw8 subtype of HLA-DR4 was associated with type I diabetes in all DR4 subgroups (DR4/3 and DR4/non-3). Dw subtypes of DR4 other than DW10 did not confer addi...

Journal: :Clinical cancer research : an official journal of the American Association for Cancer Research 2009
Agnes Elias Markus D Siegelin Albert Steinmüller Andreas von Deimling Ulrike Lass Bernhard Korn Wolf Mueller

PURPOSE To identify and characterize epigenetically regulated genes able to predict sensitivity or resistance to currently tested chemotherapeutic agents in glioma therapy. EXPERIMENTAL DESIGN We used methylation-sensitive BeadArray technology to identify novel epigenetically regulated genes associated with apoptosis and with potential therapeutic targets in glioma therapy. To elucidate the f...

Journal: :Proceedings of the National Academy of Sciences of the United States of America 1991
A R Ahmed R Wagner K Khatri G Notani Z Awdeh C A Alper E J Yunis

Previous studies demonstrated that HLA-DR4 was markedly increased among Ashkenazi Jewish patients with pemphigus vulgaris (PV), almost entirely as the common Jewish extended haplotype [HLA-B38, SC21, DR4, DQw8] or as the haplotype HLA-B35, SC31, DR4, DQw8, and that HLA-DR4, DQw8 was distributed among patients in a manner consistent with dominant expression of a class II (D-region or D-region-li...

Journal: :The Journal of biological chemistry 2008
Vicente Tur Almer M van der Sloot Carlos R Reis Eva Szegezdi Robbert H Cool Afshin Samali Luis Serrano Wim J Quax

Tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) is a potential anticancer agent that selectively induces apoptosis in a variety of cancer cells by interacting with death receptors DR4 and DR5. TRAIL can also bind to decoy receptors (DcR1, DcR2, and osteoprotegerin receptor) that cannot induce apoptosis. Different tumor types respond either to DR4 or to DR5 activation, and chemot...

2013
Junji Yatsuda Atsushi Irie Kumiko Harada Yayoi Michibata Hirotake Tsukamoto Satoru Senju Yusuke Tomita Akira Yuno Masatoshi Hirayama Mohammad Abu Sayem Naoki Takeda Isao Shibuya Shinji Sogo Fumihiro Fujiki Haruo Sugiyama Masatoshi Eto Yasuharu Nishimura

Reports have shown that activation of tumor-specific CD4(+) helper T (Th) cells is crucial for effective anti-tumor immunity and identification of Th-cell epitopes is critical for peptide vaccine-based cancer immunotherapy. Although computer algorithms are available to predict peptides with high binding affinity to a specific HLA class II molecule, the ability of those peptides to induce Th-cel...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید